 | Up a level |
Jump to: 2022
Number of items: 1.
2022
Klein, A., Zimmer, A., Hospach, T., Weller-Heinemann, F., Hansmann, S., Kuemmerle-Deschner, J., Fasshauer, M., Minden, K., Foeldvari, I., Rietschel, C., Windschall, D., Trauzeddel, R., Hufnagel, M., Foell, D., Berendes, R., Boeschow, G., Oommen, P., Dressler, F. and Horneff, G. (2022). EFFECTIVENESS AND SAFETY OF IL-6 INHIBITION (TOCILIZUMAB) VERSUS TUMOUR NECROSIS FACTOR INHIBITION IN POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE OBSERVATIONAL BIKER STUDY. Ann. Rheum. Dis., 81. S. 142 - 144. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060